Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Journal of Surgical Oncology
|
February 4, 2015
Characterization of a novel radiation-induced sarcoma cell line
Julie Lang, Weizhu Zhu, Brandon Nokes, et al.
Annals of Surgical Oncology
|
June 26, 2016
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
Robert H I Andtbacka, Merrick Ross, Igor Puzanov, et al.
Journal for Immunotherapy of Cancer
|
July 29, 2018
A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma
Joseph I Clark, Jatinder Singh, Marc S Ernstoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2024
Phase II Trial of <i>nab-</i>Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 12, 2021
<i>nab</i>-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2008
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group
David F McDermott, Jeffrey A Sosman, Rene Gonzalez, et al.
Annals of Surgical Oncology
|
July 14, 2025
Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
Annals of Surgical Oncology
|
August 31, 2025
ASO Visual Abstract: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PECOMA): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 7, 2016
Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma
Dirk Schadendorf, Reinhard Dummer, Axel Hauschild, et al.
Annals of Surgical Oncology
|
July 29, 2025
Correction: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Journal of Surgical Oncology
|
February 4, 2015
Characterization of a novel radiation-induced sarcoma cell line
Julie Lang, Weizhu Zhu, Brandon Nokes, et al.
Annals of Surgical Oncology
|
June 26, 2016
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
Robert H I Andtbacka, Merrick Ross, Igor Puzanov, et al.
Journal for Immunotherapy of Cancer
|
July 29, 2018
A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma
Joseph I Clark, Jatinder Singh, Marc S Ernstoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2024
Phase II Trial of <i>nab-</i>Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 12, 2021
<i>nab</i>-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2008
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group
David F McDermott, Jeffrey A Sosman, Rene Gonzalez, et al.
Annals of Surgical Oncology
|
July 14, 2025
Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
Annals of Surgical Oncology
|
August 31, 2025
ASO Visual Abstract: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PECOMA): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 7, 2016
Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma
Dirk Schadendorf, Reinhard Dummer, Axel Hauschild, et al.
Annals of Surgical Oncology
|
July 29, 2025
Correction: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
Page
of 3